Showing results (1-10 of 109) with videos related to
Sort By:
Pageof 11
European Journal of Clinical Pharmacology|October 24, 2012
Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EURoberta Joppi, Vittorio Bertele', Silvio GarattiniBritish Journal of Clinical Pharmacology|February 21, 2006
Orphan drug development is progressing too slowlyRoberta Joppi, Vittorio Bertele, Silvio GarattiniEuropean Journal of Internal Medicine|May 30, 2018
A disease looking for innovative drugs: The case of pulmonary arterial hypertensionRoberta Joppi, Chiara Gerardi, Vittorio Bertele', et al.British Journal of Clinical Pharmacology|October 29, 2019
Food and Drug Administration vs European Medicines Agency: Review times and clinical evidence on novel drugs at the time of approvalRoberta Joppi, Vittorio Bertele, Tommaso Vannini, et al.Recenti Progressi in Medicina|January 27, 2007
[False innovations in clinical research]Silvio Garattini, Vittorio Bertele'Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Toward new legislation on drugs in EuropeSilvio Garattini, Vittorio Bertele'European Journal of Clinical Pharmacology|May 14, 2003
Efficacy, safety and cost of new drugs acting on the central nervous systemSilvio Garattini, Vittorio Bertele'European Journal of Clinical Pharmacology|September 10, 2003
Efficacy, safety and cost of new cardiovascular drugs: a surveySilvio Garattini, Vittorio Bertele'International Review of Psychiatry (Abingdon, England)|October 1, 2005
The impact of European regulatory policies on psychotropic drug prescribing patternsSilvio Garattini, Vittorio Bertele'Pageof 11